ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

PRLD Prelude Therapeutics Inc

4,07
0,03 (0,74%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Prelude Therapeutics Inc PRLD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,03 0,74% 4,07 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,04 3,99 4,07 4,07 4,04
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.4.202422:35GLOBEPrelude Highlights Continued Strength of Discovery Engine at..
05.3.202422:45GLOBEPrelude Announces Acceptance of Multiple Preclinical..
05.3.202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:05GLOBEPrelude Therapeutics to Participate in Barclays Global..
15.2.202423:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15.2.202422:22EDGAR2Form 8-K - Current report
15.2.202422:05GLOBEPrelude Therapeutics Reports Full Year 2023 Financial..
12.2.202422:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.1.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202315:34GLOBEPrelude Therapeutics Announces $25 Million Private Placement
11.12.202315:17EDGAR2Form 8-K - Current report
01.11.202321:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.11.202321:23EDGAR2Form 8-K - Current report
01.11.202321:10GLOBEPrelude Announces Strategic Pipeline Progress and Updates,..
01.11.202321:05GLOBEPrelude Therapeutics and AbCellera Enter Partnership to..
14.10.202318:30GLOBEPrelude Announces Multiple Clinical and Preclinical Poster..
06.10.202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202314:30GLOBEPrelude Therapeutics to Participate in Three Healthcare..
03.8.202314:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202314:10EDGAR2Form 8-K - Current report
03.8.202314:00GLOBEPrelude Therapeutics Announces Second Quarter 2023 Financial..
06.7.202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.5.202314:30GLOBEPrelude Therapeutics To Participate in Jefferies Healthcare..
18.5.202313:00GLOBEPrelude Therapeutics Announces Pricing of Public Offering
17.5.202322:08GLOBEPrelude Therapeutics Announces Launch of Proposed Public..
08.5.202314:30GLOBEPrelude Therapeutics Announces First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock